You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Follicular lymphoma

Showing 5001 - 5025 of 6,008
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma Trial in Worldwide (biological, drug, procedure)

Completed
  • Lymphoma
  • filgrastim
  • +8 more
  • Sydney, New South Wales, Australia
  • +130 more
Sep 16, 2013

B-cell Lymphomas Trial in Busan (Oxaliplatin, Prednisolone)

Completed
  • B-cell Lymphomas
  • Oxaliplatin, Prednisolone
  • Busan, Korea, Republic of
    Dong-A University Hospital
Nov 2, 2014

Leukemia Trial in Houston (Erwinase)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 4, 2014

Leukemia, Lymphocytic, Chronic, B-Cell, Chronic Lymphocytic Leukemia, Lymphoma, Small Lymphocytic Trial in Atlanta

Terminated
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +2 more
  • Lenalidomide, Rituximab, and Cyclophosphamide
  • Atlanta, Georgia
    Emory University Winship Cancer Institute
Aug 12, 2014

Follicular Lymphoma Trial in Pavia (Immunochemo, in vivo purging and autrotransplant)

Completed
Has Results
  • Follicular Lymphoma
  • Immunochemotherapy, in vivo purging and autrotransplant
  • Pavia, Italy
    Division of Hematology, IRCCS Policlinico S. Matteo, University
Oct 26, 2012

Peripheral T-cell Lymphoma (Not Otherwise Specified), Angioimmunoblastic T-cell Lymphoma, Extranodal NK/T-cell Lymphoma Nasal

Completed
  • Peripheral T-cell Lymphoma (Not Otherwise Specified)
  • +6 more
  • panobinostat and bortezomib
  • Seoul, Korea, Republic of
  • +4 more
Jun 26, 2014

Lymphoma Trial in Canada, United States (IV Busulfan, Cyclophosphamide and Etoposide (BuCyE Regimen))

Completed
Has Results
  • Lymphoma
  • IV Busulfan, Cyclophosphamide and Etoposide (BuCyE Regimen)
  • Birmingham, Alabama
  • +41 more
Jul 1, 2014

Lymphoma Trial in Machester, Oxford (AZD1152)

Completed
  • Lymphoma
  • Machester, Lancashire, United Kingdom
  • +1 more
Jul 1, 2014

Cutaneous T-cell Lymphoma Trial in New Taipei City (HITS)

Unknown status
  • Cutaneous T-cell Lymphoma
  • HITS
  • New Taipei City, Taiwan
    Far Eastern Memorial Hospital
Aug 1, 2014

Childhood Burkitt Lymphoma, Childhood Diffuse Large Cell Lymphoma, Childhood Immunoblastic Large Cell Lymphoma Trial in Arcadia

Completed
Has Results
  • Childhood Burkitt Lymphoma
  • +11 more
  • doxorubicin hydrochloride
  • +13 more
  • Arcadia, California
    Children's Oncology Group
Sep 10, 2014

B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (PCI-32765)

Completed
Has Results
  • B-cell Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Boston, Massachusetts
  • +5 more
Jul 17, 2014

Lymphoma, B-Cell, Lymphoma, Large-Cell, Diffuse Trial in Dijon (R-CHOP14 induction regimen, R-ACVBP14 induction regimen)

Completed
  • Lymphoma, B-Cell
  • Lymphoma, Large-Cell, Diffuse
  • R-CHOP14 induction regimen
  • R-ACVBP14 induction regimen
  • Dijon, France
    René Olivier Casasnovas
Aug 12, 2014

Hepatitis B Virus Reactivation After Withdrawal of Prophylactic

Completed
  • Hepatitis
  • +3 more
    • Beijing, Beijing, China
      Peking University Cancer Hospital
    Jul 22, 2014

    Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma Trial

    Completed
    • Recurrent Adult Burkitt Lymphoma
    • +9 more
    • bryostatin 1
    • +2 more
    • Cleveland, Ohio
      Case Western Reserve University
    Jan 10, 2013

    Burkitt Lymphoma, B-ALL Trial in Italy (Chemotherapy-Rituximab combination)

    Completed
    • Burkitt Lymphoma
    • B-ALL
    • Chemotherapy-Rituximab combination
    • Bolzano, (bz), Italy
    • +11 more
    Sep 15, 2014

    Diffuse Large B Cell Lymphoma Trial in France (MK2206)

    Terminated
    • Diffuse Large B Cell Lymphoma
    • Bordeaux, France
    • +12 more
    Jul 9, 2014

    Brain and CNS Tumors, Breast Cancer, Extragonadal Germ Cell Tumor Trial in Birmingham (levofloxacin)

    Completed
    • Brain and Central Nervous System Tumors
    • +9 more
    • Birmingham, England, United Kingdom
      University of Birmingham
    Aug 1, 2013

    Lymphoma, Solid Tumor Trial in Scottsdale, San Antonio (drug, other, procedure)

    Terminated
    • Lymphoma
    • Unspecified Adult Solid Tumor, Protocol Specific
    • multitargeted receptor tyrosine kinase inhibitor MP470
    • +3 more
    • Scottsdale, Arizona
    • +1 more
    Aug 1, 2013

    Lymphoma Trial in Houston (Y Zevalin, In Zevalin, Rituxan)

    Completed
    Has Results
    • Lymphoma
    • Y Zevalin
    • +8 more
    • Houston, Texas
      UT MD Anderson Cancer Center
    Sep 4, 2014

    Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma Trial in

    Completed
    • Recurrent Adult Diffuse Large Cell Lymphoma
    • +2 more
    • oblimersen sodium
    • +7 more
    • Chicago, Illinois
      University of Chicago Comprehensive Cancer Center
    Jan 23, 2013

    Non-Hodgkin's Lymphoma, Diffuse Large Cell Lymphoma, Mantle Cell Lymphoma Trial in Stanford (Rituximab 375 mg/m2)

    Completed
    Has Results
    • Non-Hodgkin's Lymphoma
    • +5 more
    • Rituximab 375 mg/m2
    • Stanford, California
      Stanford University Medical Center
    Sep 4, 2014

    Non-Hodgkin's Lymphoma Trial in Worldwide (obinutuzumab (RO5072759), rituximab)

    Completed
    Has Results
    • Non-Hodgkin's Lymphoma
    • Los angeles, California
    • +70 more
    Aug 15, 2014

    Lymphoma Trial in Australia, Canada, United States (biological, drug, radiation)

    Completed
    • Lymphoma
    • filgrastim
    • +12 more
    • Long Beach, California
    • +32 more
    Jul 23, 2014

    Lymphoma Trial in Worldwide (CHOP regimen, carmustine, cyclophosphamide)

    Unknown status
    • Lymphoma
    • CHOP regimen
    • +10 more
    • Prague (Praha), Czech Republic
    • +71 more
    Sep 19, 2013

    Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in New Brunswick (rituximab, therapeutic allogeneic

    Terminated
    • Leukemia
    • +2 more
    • rituximab
    • therapeutic allogeneic lymphocytes
    • New Brunswick, New Jersey
      Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Me
    Sep 13, 2013